Follow
Cathal McCarthy
Cathal McCarthy
Department of Pharmacology & Therapeutics
Verified email at ucc.ie - Homepage
Title
Cited by
Cited by
Year
Mesenchymal stem cell inhibition of T‐helper 17 cell‐differentiation is triggered by cell–cell contact and mediated by prostaglandin E2 via the EP4 receptor
MM Duffy, J Pindjakova, SA Hanley, C McCarthy, GA Weidhofer, ...
European journal of immunology 41 (10), 2840-2851, 2011
2792011
The biology of ergothioneine, an antioxidant nutraceutical
I Borodina, LC Kenny, CM McCarthy, K Paramasivan, E Pretorius, ...
Nutrition Research Reviews 33 (2), 190-217, 2020
1662020
Therapeutically targeting mitochondrial redox signalling alleviates endothelial dysfunction in preeclampsia
C McCarthy, LC Kenny
Scientific reports 6 (1), 32683, 2016
1072016
Altered gene expression patterns in intrauterine growth restriction: potential role of hypoxia
C McCarthy, FE Cotter, S McElwaine, A Twomey, EE Mooney, F Ryan, ...
American journal of obstetrics and gynecology 196 (1), 70. e1-70. e6, 2007
1052007
Mechanisms of endothelial dysfunction in pre-eclampsia and gestational diabetes mellitus: windows into future cardiometabolic health?
CJ McElwain, E Tuboly, FP McCarthy, CM McCarthy
Frontiers in endocrinology 11, 655, 2020
882020
The potential therapeutic effects of ergothioneine in pre-eclampsia
RN Kerley, C McCarthy, DB Kell, LC Kenny
Free Radical Biology and Medicine 117, 145-157, 2018
682018
L-(+)-ergothioneine significantly improves the clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model
RD Williamson, FP McCarthy, S Manna, E Groarke, DB Kell, LC Kenny, ...
Hypertension 75 (2), 561-568, 2020
622020
Macrophage PPAR gamma Co‐activator‐1 alpha participates in repressing foam cell formation and atherosclerosis in response to conjugated linoleic acid
C McCarthy, NT Lieggi, D Barry, D Mooney, M de Gaetano, WG James, ...
EMBO molecular medicine 5 (9), 1443-1457, 2013
592013
IL‐10 mediates the immunoregulatory response in conjugated linoleic acid‐induced regression of atherosclerosis
C McCarthy, MM Duffy, D Mooney, WG James, MD Griffin, DJ Fitzgerald, ...
The FASEB Journal 27 (2), 499-510, 2013
592013
Gestational diabetes mellitus and maternal immune dysregulation: what we know so far
CJ McElwain, FP McCarthy, CM McCarthy
International Journal of Molecular Sciences 22 (8), 4261, 2021
562021
Placental ageing in adverse pregnancy outcomes: telomere shortening, cell senescence, and mitochondrial dysfunction
S Manna, C McCarthy, FP McCarthy
Oxidative medicine and cellular longevity 2019, 2019
562019
Oxidative stress in pre-eclampsia; have we been looking in the wrong place?
RD Williamson, C McCarthy, FP McCarthy, LC Kenny
Pregnancy Hypertension: An International Journal of Women's Cardiovascular …, 2017
522017
Preeclampsia and neurodevelopmental outcomes: potential pathogenic roles for inflammation and oxidative stress?
A Barron, CM McCarthy, GW O’Keeffe
Molecular Neurobiology 58 (6), 2734-2756, 2021
482021
Conjugated linoleic acid suppresses the migratory and inflammatory phenotype of the monocyte/macrophage cell
S McClelland, C Cox, R O’Connor, M de Gaetano, C McCarthy, L Cryan, ...
Atherosclerosis 211 (1), 96-102, 2010
482010
Activation of a TLR9 mediated innate immune response in preeclampsia
RD Williamson, FP McCarthy, LC Kenny, CM McCarthy
Scientific Reports 9 (1), 5920, 2019
412019
Immunostimulatory role of mitochondrial DAMP s: alarming for pre‐eclampsia?
CM McCarthy, LC Kenny
American journal of reproductive immunology 76 (5), 341-347, 2016
382016
A perspective on pre-eclampsia and neurodevelopmental outcomes in the offspring: Does maternal inflammation play a role?
GM Maher, FP McCarthy, CM McCarthy, LC Kenny, PM Kearney, ...
International journal of developmental neuroscience 77, 69-76, 2019
342019
Mitochondrial [dys]function: a culprit in pre-eclampsia?
KLC McCarthy CM
Clinical Science 130 (14), 1179, 2016
332016
Standardization of models and methods used to assess nanoparticles in cardiovascular applications
KT Fitzgerald, CA Holladay, C McCarthy, KA Power, A Pandit, ...
Small 7 (6), 705-717, 2011
302011
microRNA-155 is decreased during atherosclerosis regression and is increased in urinary extracellular vesicles during atherosclerosis progression
S Fitzsimons, S Oggero, R Bruen, C McCarthy, NG Mahon, N Ryan, ...
Frontiers in Immunology 11, 576516, 2020
282020
The system can't perform the operation now. Try again later.
Articles 1–20